Valsartan
Who holds supplier records for Valsartan? 35 organisations hold a current record for Valsartan: an active US FDA Type II Drug Master File or a CEP. A further 5 organisations have only historical (inactive) DMF filings. 27 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (23), China (7), Netherlands (2), United States (1) and 1 other country (1); not recorded for 1.
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Valsartan: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/valsartan
Reading the evidence
- 35 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- Most recorded organisations are in India
23 of the 34 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.
- 21 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
Current records (35)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Valsartan. Country is the organisation's recorded country, not necessarily the manufacturing site.
- CHANGZHOU PHARMACEUTICAL FACTORYChinaCEP Company GMP cert on recordActive DMF 42015, 41094 · latest filing May 2025
- Zhejiang Tianyu Pharmaceutical Co., Ltd.ChinaCEPActive DMF 33475, 32175 · latest filing Dec 2018
- ZHUHAI RUNDU PHARMACEUTICAL CO LTDChinaCEPActive DMF 32328, 25510, 33471 · latest filing Jan 2019
- LINHAI TIANYU PHARMACEUTICAL CO LTDChinaActive DMF 41622, 42563 · latest filing Sept 2025
- Alembic Pharmaceuticals LimitedIndiaCEP Company GMP cert on recordActive DMF 21134, 27780, 23584 · latest filing Dec 2013
- APITORIA PHARMA PRIVATE LTDIndiaCEP Company GMP cert on recordActive DMF 24544 · latest filing Mar 2011
- BIOPHORE INDIA PHARMACEUTICALS PRIVATE LIMITEDIndiaCEPActive DMF 35510 · latest filing Dec 2020
- Divis LaboratoriesIndiaCEP Company GMP cert on recordActive DMF 24797 · latest filing Mar 2011
- Dr. Reddy's Laboratories Ltd.IndiaCEP Company GMP cert on recordActive DMF 20319 · latest filing Mar 2007
- HARMAN FINOCHEM LTDIndiaCEP Company GMP cert on recordActive DMF 34287 · latest filing Nov 2019
- Hetero Labs LimitedIndiaCEP Company GMP cert on recordActive DMF 29392, 26397, 24873 · latest filing May 2015
- Iol Chemicals And Pharmaceuticals LimitedIndiaCEP Company GMP cert on recordActive DMF 38339 · latest filing Aug 2023
- Ipca Laboratories LimitedIndiaCEP Company GMP cert on recordActive DMF 22614, 28824 · latest filing Mar 2016
- JUBILANT BIOSYS LTDIndiaCEPActive DMF 18967 · latest filing Nov 2005
- Macleods Pharmaceuticals Ltd.IndiaCEP Company GMP cert on recordActive DMF 24178 · latest filing Sept 2010
- MATRIX PHARMACORP PRIVATE LTDIndiaCEPActive DMF 18253 · latest filing Apr 2005
- MSN LIFE SCIENCES PRIVATE LIMITEDIndiaCEP Company GMP cert on recordActive DMF 31598 · latest filing Mar 2018
- SECOND PHARMA CO LTDChinaCEPActive DMF 25848 · latest filing Mar 2012
- TAPI NL BVNetherlandsCEPActive DMF 24724 · latest filing Jan 2011
- Zhejiang Huahai Pharmaceutical Co., Ltd.ChinaCEP Company GMP cert on recordActive DMF 20939, 23491 · latest filing Jan 2010
- Zydus Lifesciences LimitedIndiaCEP Company GMP cert on recordActive DMF 34826 · latest filing Apr 2020
- Biocon LimitedIndiaActive DMF 33427 · latest filing Mar 2019
- Cadila Pharmaceuticals LimitedIndia Company GMP cert on recordActive DMF 22183, 26167 · latest filing Jul 2012
- Laurus Labs LimitedIndia Company GMP cert on recordActive DMF 38450 · latest filing Aug 2023
- Lupin LimitedIndia Company GMP cert on recordActive DMF 19301 · latest filing Mar 2006
- Mankind Pharma LimitedIndia Company GMP cert on recordActive DMF 36203 · latest filing Nov 2021
- NOVARTIS PHARMACEUTICALS CORPUnited States Company GMP cert on recordActive DMF 23902 · latest filing Jul 2010
- SynthonNetherlands Company GMP cert on recordActive DMF 33648 · latest filing Mar 2019
- CHROMO LABORATORIES INDIA PRIVATE LTDIndiaCEPInactive DMF 33586 · latest filing Mar 2019
- NINGBO MENOVO PHARMACEUTICAL CO LTDChinaCEPInactive DMF 33254 · latest filing Oct 2018
- NOVARTIS PHARMA AGCEP Company GMP cert on record
- IndiaCEP
- Sun Pharmaceutical Industries LimitedIndiaCEP Company GMP cert on recordInactive DMF 33770, 17897 · latest filing Jun 2019
- CPL PHARMACEUTICALS PRIVATE LIMITEDIndiaCEPValid CEP holder (EDQM); not necessarily the manufacturer
- KRKA, d.d.SloveniaCEPValid CEP holder (EDQM); not necessarily the manufacturer
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Valid CEP holder entries (27)
Certificates of Suitability on the EDQM register for Valsartan, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 50 certificates in total, including withdrawn, expired, suspended and repeat certificates.
| Holder | Country | Certificate | Issued | EU GMP at holder's address |
|---|---|---|---|---|
| CHROMO LABORATORIES INDIA PRIVATE LIMITED Pashamylaram | IN | CEP 2018-116 - Rev 02 Valsartan | Oct 2026 | — |
| JUBILANT BIOSYS LIMITED Mysuru | IN | CEP 2011-110 - Rev 11 Valsartan | Sept 2026 | — |
| MATRIX PHARMACORP PRIVATE LIMITED Sangareddy | IN | CEP 2024-113 - Rev 04 Valsartan, Process III | Jun 2026 | — |
| Changzhou Pharmaceutical Factory Changzhou | CN | CEP 2025-430 - Rev 00 Valsartan | May 2026 | Inspected Apr 2025 Italy |
| ZHUHAI RUNDU PHARMACEUTICAL CO., LTD. Zhuhai | CN | CEP 2019-106 - Rev 03 Valsartan | Apr 2026 | — |
| HETERO LABS LIMITED Hyderabad | IN | CEP 2021-152 - Rev 02 Valsartan, VL Process Essentially Amorphous Form | Feb 2026 | — |
| MACLEODS PHARMACEUTICALS LIMITED Mumbai | IN | CEP 2025-145 - Rev 00 Valsartan, (1582) | Feb 2026 | — |
| ALEMBIC PHARMACEUTICALS LIMITED Vadodara | IN | CEP 2010-065 - Rev 09 Valsartan | Jan 2026 | — |
| DR. REDDY'S LABORATORIES LIMITED Hyderabad | IN | CEP 2025-449 - Rev 00 Valsartan, Essential Amorphous Form, Process-II | Nov 2025 | — |
| IPCA LABORATORIES LIMITED Mumbai | IN | CEP 2010-100 - Rev 06 Valsartan | Sept 2025 | — |
| NINGBO MENOVO PHARMACEUTICAL CO., LTD. Ningbo | CN | CEP 2019-258 - Rev 02 Valsartan | Aug 2025 | — |
| CPL PHARMACEUTICALS PRIVATE LIMITED Ahmedabad | IN | CEP 2023-282 - Rev 00 Valsartan | Apr 2025 | — |
| ZHEJIANG TIANYU PHARMACEUTICAL CO., LTD. Taizhou City | CN | CEP 2020-389 - Rev 04 Valsartan, Process-II | Mar 2025 | — |
| TAPI NL B.V. Amsterdam | NL | CEP 2011-121 - Rev 05 Valsartan, ID: 7611 | Jan 2025 | — |
| MSN LIFE SCIENCES PRIVATE LIMITED Chandampet Village | IN | CEP 2018-275 - Rev 04 Valsartan, Micronised and non-micronised | Jan 2025 | Inspected Oct 2025 Slovakia |
| NOVARTIS PHARMA AG Basel | CH | CEP 2016-290 - Rev 03 Valsartan | Oct 2024 | Inspected Dec 2025 Switzerland |
| HARMAN FINOCHEM LIMITED Mumbai | IN | CEP 2016-026 - Rev 01 Valsartan | Sept 2024 | — |
| KRKA, d.d., Novo mesto Novo mesto | SI | CEP 2024-137 - Rev 00 Valsartan, 319192 | Aug 2024 | Inspected Jul 2025 Slovenia |
| SMILAX LABORATORIES LIMITED Hyderabad | IN | CEP 2023-166 - Rev 00 Valsartan | Aug 2024 | — |
| IOL CHEMICALS AND PHARMACEUTICALS LTD Ludhiana | IN | CEP 2023-264 - Rev 00 Valsartan | Jul 2024 | — |
| SECOND PHARMA CO., LTD. Shangyu City | CN | CEP 2014-008 - Rev 02 Valsartan | Jul 2024 | — |
| ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. Linhai | CN | CEP 2023-212 - Rev 01 Valsartan, Process II | May 2024 | Inspected May 2026 Italy |
| SUN PHARMACEUTICAL INDUSTRIES LIMITED Mumbai | IN | CEP 2013-335 - Rev 06 Valsartan, Process 5 | Jan 2024 | — |
| APITORIA PHARMA PRIVATE LIMITED Hyderabad | IN | CEP 2021-306 - Rev 01 Valsartan, BARIUM SALT PROCESS | Jan 2024 | — |
| ZYDUS LIFESCIENCES LIMITED Vadodara | IN | R0-CEP 2020-221 - Rev 00 Valsartan | Apr 2023 | — |
| BIOPHORE INDIA PHARMACEUTICALS PVT. LTD. Hyderabad | IN | R0-CEP 2021-097 - Rev 00 Valsartan | Feb 2023 | — |
| DIVI'S LABORATORIES LIMITED Hyderabad | IN | R1-CEP 2012-338 - Rev 01 Valsartan | May 2020 | — |
The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.
Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.
Historical records (5)
Organisations whose Type II DMFs for Valsartan are no longer active. These show a past filing, not current supply.
Show all 5 historical records
- China · Inactive DMF 26690 · filed Dec 2012
- SIGNA SA DE CVInactive DMF 23150 · filed Oct 2009
- India · Inactive DMF 22684 · filed Mar 2009
- India · Inactive DMF 21845 · filed Jul 2008
- Teva Pharmaceutical Industries Ltd.Israel · Inactive DMF 17909 · filed Dec 2004
Overview
Valsartan is an angiotensin II receptor blocker (ARB) used in the management of hypertension and heart failure. It works by relaxing blood vessels so that blood can flow more easily.
Chemical identity
- IUPAC name
- (2S)-3-methyl-2-[pentanoyl-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]amino]butanoic acid
- Canonical SMILES
- CCCCC(=O)N(CC1=CC=C(C=C1)C2=CC=CC=C2C3=NNN=N3)[C@@H](C(C)C)C(=O)O
- InChIKey
- ACWBQPMHZXGDFX-QFIPXVFZSA-N
- Synonyms
- agsav301 component valsartan, cgp-48933, cgp48933, copalia component valsartan, copalia-hct component valsartan, dafiro component valsartan, dafiro-hct component valsartan, diovan, diovan hct component valsartan, entresto component valsartan, exforge component valsartan, exforge hct component valsartan
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Angiotensin 2 Receptor Blocker
- Mechanism of action
- Angiotensin 2 Receptor Antagonists
Therapeutic areas
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Valsartan?
35 organisations hold an active US FDA Type II Drug Master File or a CEP for Valsartan: CHANGZHOU PHARMACEUTICAL FACTORY (China), Zhejiang Tianyu Pharmaceutical Co., Ltd. (China), ZHUHAI RUNDU PHARMACEUTICAL CO LTD (China), LINHAI TIANYU PHARMACEUTICAL CO LTD (China), Alembic Pharmaceuticals Limited (India), APITORIA PHARMA PRIVATE LTD (India), BIOPHORE INDIA PHARMACEUTICALS PRIVATE LIMITED (India) and Divis Laboratories (India), and 27 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Valsartan Drug Master Files are active?
CHANGZHOU PHARMACEUTICAL FACTORY (DMF 42015, 41094), Zhejiang Tianyu Pharmaceutical Co., Ltd. (DMF 33475, 32175), ZHUHAI RUNDU PHARMACEUTICAL CO LTD (DMF 32328, 25510), LINHAI TIANYU PHARMACEUTICAL CO LTD (DMF 41622, 42563), Alembic Pharmaceuticals Limited (DMF 21134, 27780), APITORIA PHARMA PRIVATE LTD (DMF 24544), BIOPHORE INDIA PHARMACEUTICALS PRIVATE LIMITED (DMF 35510) and Divis Laboratories (DMF 24797) and 20 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Valsartan records mean?
5 organisations have only inactive Type II DMFs for Valsartan. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
Does Valsartan have a European Certificate of Suitability?
Yes. 27 organisations hold a valid CEP for Valsartan on the EDQM register, including CHROMO LABORATORIES INDIA PRIVATE LIMITED Pashamylaram (IN), JUBILANT BIOSYS LIMITED Mysuru (IN), MATRIX PHARMACORP PRIVATE LIMITED Sangareddy (IN), Changzhou Pharmaceutical Factory Changzhou (CN), ZHUHAI RUNDU PHARMACEUTICAL CO., LTD. Zhuhai (CN) and HETERO LABS LIMITED Hyderabad (IN) and 21 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
How do I qualify a Valsartan supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Valsartan?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.